# Understanding pLDDT Scores: How to Interpret AlphaFold's Confidence Metric

Researchers using AlphaFold for protein structure prediction face a practical problem: the software produces a three-dimensional model for nearly any protein sequence, but not every region of that model is equally reliable. The predicted local distance difference test, or pLDDT, is the confidence metric AlphaFold assigns to each residue in the model. This article explains what pLDDT values mean, how they correlate with expected structural accuracy, and how to use them to identify high-confidence versus low-confidence regions in your predictions. The guidance applies to biology students, researchers, laboratory professionals, and life-science practitioners who need to make informed decisions about which parts of an AlphaFold model to trust for downstream analysis such as molecular docking, variant interpretation, or experimental design.

## What pLDDT Scores Measure

pLDDT is a per-residue confidence score that AlphaFold assigns to each amino acid position in a predicted structure. The score ranges from 0 to 100, with higher values indicating greater predicted confidence in the local structural arrangement around that residue. The metric is calibrated so that residues with high pLDDT values are expected to be modeled with accuracy approaching that of experimental structures, while residues with low pLDDT values are likely to be poorly constrained by the sequence and may adopt multiple conformations in reality.

The pLDDT score is not a direct measurement of accuracy. It is a prediction of how confident the model is in its own local structure prediction. This distinction matters for interpretation. A high pLDDT does not guarantee that the residue is positioned correctly in the global fold, and a low pLDDT does not necessarily mean the residue is functionally unimportant. Rather, pLDDT provides a probabilistic estimate of the local error that can be expected at each position.

For practical purposes, researchers commonly divide pLDDT values into confidence bands. Residues with pLDDT above 90 are considered very high confidence and are often comparable to experimental structures. Residues between 70 and 90 are considered confident and are generally reliable for most analyses. Residues between 50 and 70 are considered low confidence and may have errors in loop geometry or side chain placement. Residues below 50 are considered very low confidence and are often found in intrinsically disordered regions or in segments that lack strong evolutionary constraints.

These thresholds are practical heuristics instead of absolute guarantees. The relationship between pLDDT and actual accuracy has been examined in multiple benchmark studies, and the general trend holds across diverse protein families. However, the precise error at a given pLDDT value can vary depending on the protein system, the multiple sequence alignment depth, and the presence of ligands or other interacting partners.

## At a Glance: pLDDT Interpretation Table

| pLDDT Range | Confidence Level | Expected Accuracy | Recommended Use |
|-------------|------------------|-------------------|-----------------|
| 90 to 100 | Very high | Near experimental quality, backbone atoms typically within 1 Å of true structure | Molecular docking, active site analysis, variant interpretation, structure-based drug design |
| 70 to 90 | High | Good backbone accuracy, side chain positions may have minor errors | Domain architecture analysis, fold classification, mutation effect studies with caution |
| 50 to 70 | Low | Loop regions and surface segments may be inaccurate, topology generally preserved | Secondary structure assignment, identifying domain boundaries, not suitable for fine-grained analysis |
| 0 to 50 | Very low | Structure largely unreliable, often disordered or flexible regions | Identifying intrinsically disordered regions, recognizing flexible linkers, avoiding these regions for docking or binding site analysis |

## The Relationship Between pLDDT and Structural Accuracy

The pLDDT score correlates with the expected local distance difference test, which measures the similarity between the predicted structure and the true structure in terms of local distances. When AlphaFold produces a model, it internally estimates how well the predicted local distances match what would be expected for a correct structure. This internal estimate is converted into the pLDDT score that is output with the model.

Benchmark studies have quantified this relationship. In an assessment of AlphaFold2 predictions for human proteins, researchers compared predicted structures against experimental structures from the Protein Data Bank. They found that larger deviations from experimental structures occurred in regions with lower pLDDT scores. The study examined 1264 comparative pairs comprising 115 unique AlphaFold2 structures and 652 unique experimental structures, and the results showed that exposed residues and polar residues such as aspartate, glutamate, and asparagine were described less accurately than hydrophobic residues. Proline conformations were the hardest to predict, likely because proline frequently appears in dynamic solvent-accessible parts of proteins. These findings support the practical rule that lower pLDDT values correspond to higher expected error, particularly for surface residues and residues with specific physicochemical properties.

The same study found that AlphaFold2 performed markedly worse for multimers than for monomers. Ligands, cofactors, and experimental resolution were not very important for performance. This means that when you are working with a monomeric protein, you can generally trust high pLDDT regions more than when you are working with a multimeric complex. The confidence score reflects the model's certainty about the local structure given the sequence and the evolutionary information available, and for multimeric proteins the model has less information about how the subunits interact.

## pLDDT as a Proxy for Protein Dynamics

Beyond static accuracy, pLDDT scores carry information about protein dynamics. Research has shown that AlphaFold2 predictions encode residue flexibility information through both pLDDT scores and predicted aligned error maps. In a study of various protein systems including globular proteins, a multi-domain protein, an intrinsically disordered protein, a randomized protein, two larger proteins over 1000 amino acids, a heterodimer, and a homodimer complex, researchers found that pLDDT-derived scores correlated highly with root mean square fluctuations calculated from molecular dynamics simulations for most protein models.

This correlation means that residues with low pLDDT values are often flexible residues that move significantly in molecular dynamics simulations. The practical implication is that pLDDT can serve as a fast proxy for identifying flexible regions without running expensive molecular dynamics simulations. For most folded proteins, the pLDDT profile along the sequence gives a reasonable picture of which regions are rigid and which are mobile.

The same study found an important exception. For an intrinsically disordered protein and a randomized protein, the pLDDT-derived scores did not correlate with root mean square fluctuations from molecular dynamics, especially for the intrinsically disordered protein. This makes sense because intrinsically disordered proteins lack a stable three-dimensional structure, and the pLDDT scores reflect the model's uncertainty about the structure instead of a specific dynamic behavior. In these cases, low pLDDT values indicate that the region is likely disordered, but the precise dynamic behavior cannot be inferred from the pLDDT alone.

## Using pLDDT to Identify Intrinsically Disordered Regions

One of the most practical uses of pLDDT scores is identifying intrinsically disordered regions. Intrinsically disordered regions are protein segments that lack a stable three-dimensional structure under physiological conditions. AlphaFold2 typically represents these regions as long extended loops that appear to float around the structured core. The pLDDT values in these regions are usually low, often below 50, reflecting the model's inability to confidently predict a specific structure.

Research comparing AlphaFold2 and AlphaFold3 on disorder prediction using the CAID3 benchmark found that AlphaFold2 remains the preferred choice for identifying intrinsically disordered regions. AlphaFold3 introduced architectural and training modifications aimed at reducing structural hallucinations in disordered regions, but it did not outperform AlphaFold2 on the disorder prediction benchmark. The study also found that solvent accessibility remains a robust and consistent proxy for predicting intrinsic disorder across both models.

For researchers, this means that a low pLDDT region, especially one that is also predicted to be solvent accessible, is strong evidence for intrinsic disorder. This information is valuable for experimental design. If you are planning to express and purify a protein for structural studies, you may want to remove or tag disordered regions to improve crystallization or cryo-EM sample quality. If you are studying protein function, disordered regions may be involved in protein-protein interactions or post-translational modification sites, and their flexibility is functionally relevant.

## pLDDT in Variant Effect Prediction

The integration of pLDDT scores into variant effect prediction is an active area of research. Missense variants, which change one amino acid to another, can have pathogenic effects by disrupting protein structure, stability, or interactions. Structure-based approaches to variant interpretation use predicted structures to assess whether a variant is likely to disrupt the protein.

A review of methods for predicting the impact of missense variants using structural information described VarMeter, a computational framework incorporating three-dimensional structural parameters that has been applied to predict pathogenic variants in the ClinVar database. The updated version, VarMeter2, integrates AlphaFold-derived pLDDT confidence scores and Mahalanobis distance analysis to improve prediction accuracy. The framework demonstrated its ability to predict pathogenic variants of four glycan-related proteins.

The practical implication is that pLDDT scores can inform variant interpretation. A missense variant in a high pLDDT region is more likely to have a structural effect because the region is confidently modeled and likely important for the protein fold. A variant in a low pLDDT region may be in a flexible or disordered segment where structural disruption is less likely to be the mechanism of pathogenicity. However, pLDDT is only one input among many, and variant interpretation should consider evolutionary conservation, biochemical properties of the amino acid substitution, and experimental evidence.

## Practical Workflow for Assessing pLDDT Scores

When you receive an AlphaFold prediction, the pLDDT scores are typically provided in the output files. The B-factor column in the PDB file often contains the pLDDT values, and the JSON format output includes per-residue confidence scores. Here is a practical workflow for using pLDDT scores in your analysis.

First, visualize the pLDDT scores along the protein sequence. Most structural visualization software can color the model by pLDDT, with blue indicating high confidence and red indicating low confidence. This gives you an immediate visual sense of which regions are reliable. Alternatively, you can plot the pLDDT values as a function of residue number to see the confidence profile across the sequence.

Second, identify the high-confidence core. Residues with pLDDT above 70 generally form the structured core of the protein. These regions are suitable for most structural analyses, including fold identification, domain assignment, and active site characterization. If you are planning molecular docking, focus on binding sites that fall within high-confidence regions.

Third, flag the low-confidence regions. Residues with pLDDT below 50 are likely disordered or flexible. These regions should be excluded from analyses that assume a fixed structure, such as docking or structure-based drug design. They may also be regions where the model has hallucinated a structure that does not exist in reality.

Fourth, check the predicted aligned error map. The predicted aligned error map provides information about the relative confidence of different domains. If two domains have high pLDDT individually but the predicted aligned error between them is high, the relative orientation of the domains is uncertain. This is common in multi-domain proteins where the linker between domains is flexible.

Fifth, compare with experimental information if available. If you have experimental structures for homologous proteins, compare the predicted structure with the experimental structure in high-confidence regions. This validation step can help you calibrate your confidence in the prediction.

## Records and Measurements for pLDDT Assessment

Keeping systematic records of pLDDT assessments is important for reproducibility and for building confidence in your predictions over time. For each protein you analyze, record the following information.

The protein identifier and sequence version should be documented. AlphaFold predictions are sequence-specific, and changes to the sequence, such as the addition of tags or the removal of signal peptides, can affect the prediction. Record the exact sequence used for the prediction.

The pLDDT distribution should be summarized numerically. Calculate the mean pLDDT, the median pLDDT, and the fraction of residues in each confidence band. These summary statistics give you a quick sense of the overall quality of the model. A protein with a mean pLDDT above 80 is generally well predicted, while a protein with a mean pLDDT below 60 may have substantial regions of uncertainty.

The location of low-confidence regions should be mapped to the sequence. Record the residue ranges with pLDDT below 50 and below 70. These regions are candidates for disorder or flexibility, and they should be noted in any downstream analysis.

The predicted aligned error map should be assessed for domain orientation confidence. If the protein has multiple domains, record the predicted aligned error between domains. High predicted aligned error between domains indicates that the relative orientation is uncertain, which limits the usefulness of the model for analyses that depend on the overall shape of the protein.

Finally, record any experimental validation data. If you have experimental structures, cross-linking data, or mutagenesis data that confirm or contradict the prediction, document these findings. This information is valuable for calibrating your interpretation of pLDDT scores for future predictions.

## Common Failure Patterns in pLDDT Interpretation

Several common mistakes occur when researchers interpret pLDDT scores. Being aware of these failure patterns can help you avoid them.

The first failure pattern is treating pLDDT as a direct measure of accuracy. pLDDT is a predicted confidence, not a measured accuracy. A high pLDDT region can still be wrong, particularly if the multiple sequence alignment is shallow or if the protein has unusual features. Conversely, a low pLDDT region can sometimes be correctly modeled, especially if the low confidence arises from flexibility instead of error.

The second failure pattern is ignoring the predicted aligned error map. Two proteins can have identical pLDDT profiles but very different domain orientations. If you only look at pLDDT and ignore the predicted aligned error, you may incorrectly assume that the overall fold is reliable when only the individual domains are reliable.

The third failure pattern is using low pLDDT regions for docking or binding site analysis. Low pLDDT regions are often flexible or disordered, and their conformations in the predicted model may not represent the biologically relevant conformation. Docking into these regions can produce misleading results.

The fourth failure pattern is assuming that all high pLDDT regions are equally reliable. The relationship between pLDDT and accuracy can vary by residue type and by structural context. Surface residues, particularly polar and charged residues, tend to be less accurately modeled than buried hydrophobic residues at the same pLDDT value. Proline residues are particularly challenging to predict accurately.

The fifth failure pattern is overinterpreting the structure of multimeric complexes. AlphaFold2 performs markedly worse for multimers than for monomers. If you are using AlphaFold to predict a protein complex, the pLDDT scores for the interface regions may be less reliable than the pLDDT scores for the monomer cores.

## Limitations of pLDDT Scores

pLDDT scores have inherent limitations that should be acknowledged in any analysis. The scores are calibrated on the training data used to develop AlphaFold, and the relationship between pLDDT and accuracy may differ for protein families that are underrepresented in the training data.

The depth and quality of the multiple sequence alignment affect pLDDT reliability. Proteins with few homologs in the sequence databases tend to have lower pLDDT scores, and the scores may be less informative for these proteins. Conversely, proteins with deep multiple sequence alignments tend to have higher pLDDT scores, and the scores are more reliable.

pLDDT does not capture all sources of structural uncertainty. The score reflects local confidence, but it does not fully capture uncertainty in domain orientation, which is better assessed through the predicted aligned error map. It also does not capture the effects of ligands, cofactors, or post-translational modifications on protein structure. AlphaFold predictions are for the apo protein, and the presence of binding partners can induce conformational changes that are not reflected in the prediction.

For intrinsically disordered proteins, pLDDT scores indicate that the region is likely disordered, but they do not provide information about the conformational ensemble. The dynamic behavior of disordered regions cannot be inferred from pLDDT alone, and molecular dynamics simulations or experimental techniques such as nuclear magnetic resonance spectroscopy are needed to characterize the dynamics.

## pLDDT in the Context of Protein Kinase Modeling

The application of pLDDT scores to protein kinase modeling provides a concrete example of how the metric can guide model selection. Human cells contain 437 catalytically competent protein kinase domains with the typical kinase fold, but only 155 of these kinases are available in the Protein Data Bank in their active form. Researchers used AlphaFold2 to produce models of all 437 human protein kinases in the active form, using templates from the Protein Data Bank and shallow multiple sequence alignments of orthologs and close homologs.

The researchers selected models for each kinase based on the pLDDT scores of the activation loop residues. The highest scoring models had the lowest or close to the lowest root mean square deviation to 22 non-redundant substrate-bound structures in the Protein Data Bank. In a larger benchmark of all 130 active kinase structures with complete activation loops in the Protein Data Bank, 80 percent of the highest-scoring AlphaFold2 models had root mean square deviation below 1.0 angstrom and 90 percent had root mean square deviation below 2.0 angstrom over the activation loop backbone atoms.

This example illustrates a key practical point. When you need to select among multiple predicted models or when you need to assess whether a specific region of a model is reliable, the pLDDT score for that region is a useful selection criterion. The activation loop of protein kinases is functionally critical, and using pLDDT to select models with confident activation loop predictions produced models that closely matched experimental structures.

## Professional Escalation Criteria for pLDDT Assessment

There are situations where pLDDT assessment indicates that you should escalate your analysis to more sophisticated methods or seek additional experimental information. Recognizing these situations can save time and prevent incorrect conclusions.

If the mean pLDDT of your protein model is below 50, the overall model is likely unreliable. This situation can occur for proteins with very few homologs, for proteins with large disordered regions, or for proteins that are difficult to predict. In this case, you should consider whether experimental structure determination is necessary or whether alternative prediction methods might perform better.

If the pLDDT scores are high but the predicted aligned error map shows high uncertainty between domains, the domain orientations are not reliable. This situation is common in multi-domain proteins with flexible linkers. For analyses that depend on the overall shape of the protein, such as small-angle X-ray scattering modeling or docking of multi-domain complexes, you should seek experimental information about domain orientations, such as cross-linking mass spectrometry or small-angle X-ray scattering data.

If you are working with a multimeric complex and the interface regions have low pLDDT, the predicted interface may not be accurate. AlphaFold2 performs worse for multimers, and the interface predictions should be validated experimentally. Techniques such as cross-linking mass spectrometry, mutagenesis, or co-immunoprecipitation can provide evidence about the biological interface.

If you are interpreting missense variants and the variant falls in a low pLDDT region, the structural interpretation is uncertain. The variant may affect protein function through mechanisms other than structural disruption, such as affecting interactions or post-translational modifications. In this case, you should consider functional assays or consult the clinical literature for evidence about the variant.

If you are planning molecular docking and the binding site falls in a low pLDDT region, the docking results will be unreliable. The binding site conformation may not be accurately modeled, and the docking calculations may produce false positives or false negatives. You should consider experimental structure determination of the protein with the ligand bound, or you should use ensemble docking approaches that account for protein flexibility.

## Quality Controls for pLDDT-Based Analysis

Implementing quality controls in your pLDDT-based analysis workflow helps ensure that your conclusions are robust. The following controls are recommended for research and laboratory settings.

Always report the pLDDT distribution alongside any structural conclusions. A statement such as "the model has a mean pLDDT of 85 with 90 percent of residues above 70" provides context for the reliability of the analysis. This practice is particularly important in publications and reports where readers need to assess the strength of the evidence.

Validate high-confidence predictions against experimental data when available. If you have an experimental structure for a homologous protein, compare the predicted structure with the experimental structure in the high-confidence regions. This comparison provides an empirical check on the relationship between pLDDT and accuracy for your specific protein family.

Use multiple prediction methods when the pLDDT scores are ambiguous. If a region has intermediate pLDDT values between 50 and 70, the structure is uncertain, and different prediction methods may give different results. Comparing predictions from multiple methods can help you identify regions that are consistently predicted versus regions that are method-dependent.

Document the multiple sequence alignment depth and quality. The pLDDT scores depend on the evolutionary information available, and shallow alignments produce less reliable predictions. Recording the number of sequences in the alignment and the sequence coverage helps you assess the reliability of the prediction.

For downstream applications such as docking or variant interpretation, filter the analysis to high-confidence regions. This filtering reduces the risk of drawing conclusions from unreliable structural regions. If the analysis requires including low-confidence regions, acknowledge the limitation and consider experimental validation.

## Safety and Reproducibility Context

The reproducibility of pLDDT-based analyses depends on the version of AlphaFold used, the database versions, and the parameters chosen. Different versions of AlphaFold may produce different predictions for the same sequence, and the pLDDT scores may differ between versions. When reporting results, document the software version, the database versions, and any non-default parameters.

The comparison between AlphaFold2 and AlphaFold3 for intrinsically disordered region prediction illustrates this point. AlphaFold3 introduced architectural and training modifications, including cross-distillation aimed at reducing structural hallucinations in disordered regions. However, the evaluation showed that AlphaFold3 did not outperform AlphaFold2 on the disorder prediction benchmark, and changes in the predicted secondary structure content and pLDDT scores led to different interpretations of disorder. This finding underscores the importance of documenting the software version and understanding how version differences affect pLDDT interpretation.

For laboratory professionals, the practical implication is that pLDDT-based conclusions should be tied to the specific prediction run. If you update AlphaFold or the underlying databases, you should re-evaluate your predictions and confirm that your conclusions remain valid. This is particularly important for long-term projects where predictions may be revisited months or years after the initial analysis.

## Building a pLDDT Decision Framework for Residue-Level Analysis

A common gap in pLDDT interpretation is the absence of a structured decision process that translates confidence scores into concrete research actions. Researchers often know that high pLDDT is good and low pLDDT is bad, but they lack a systematic method for deciding what to do with each residue or region. This section provides a practical decision framework that connects pLDDT values to specific analytical choices, experimental planning steps, and documentation requirements.

### The Residue-Level Triage System

The triage system organizes pLDDT interpretation into three action categories: trust, test, and treat. Each category corresponds to a different level of confidence and a different set of appropriate downstream actions. This framework is designed to be applied residue by residue or region by region, depending on the granularity of your analysis.

The trust category includes residues with pLDDT above 70. These residues are suitable for direct structural interpretation without additional validation. You can use them for active site characterization, fold assignment, domain boundary identification, and structure-based hypothesis generation. When you build molecular models for docking or when you design mutagenesis experiments targeting specific residues, the trust category provides your primary working set.

The test category includes residues with pLDDT between 50 and 70. These residues require additional evidence before you draw structural conclusions. The backbone topology is probably correct, but side chain positions and loop geometry may contain errors. For these residues, you should seek corroborating evidence from experimental data, homologous structures, or complementary computational methods. If you are designing experiments around residues in this category, you should include validation steps such as cross-linking data, mutagenesis controls, or comparison with related experimental structures.

The treat category includes residues with pLDDT below 50. These residues should be treated as structurally unreliable for most purposes. They are likely disordered, flexible, or poorly constrained by evolutionary information. You should exclude them from docking calculations, binding site analysis, and structure-based variant interpretation. If these residues are functionally important, you should plan experimental characterization using techniques that do not depend on a fixed three-dimensional structure, such as nuclear magnetic resonance spectroscopy, hydrogen-deuterium exchange, or limited proteolysis.

### Applying the Framework to Common Research Tasks

The triage system translates directly into decisions for specific research tasks. For molecular docking, restrict your search space to residues in the trust category. If your putative binding site includes residues from the test or treat categories, the docking results should be interpreted with caution or validated experimentally. The presence of low-confidence residues in a binding site does not mean the site is wrong, but it does mean that the predicted conformation of those residues may not represent the biologically relevant arrangement.

For variant effect prediction, prioritize variants located in the trust category. A missense variant in a high-confidence region is more likely to disrupt the protein fold or a functional interface. Variants in the test category require additional evidence from evolutionary conservation or functional assays. Variants in the treat category are less likely to exert their effects through structural disruption, and you should consider alternative mechanisms such as altered interactions, changes in post-translational modification, or effects on protein dynamics.

For experimental design, use the framework to guide construct design and sample preparation. If you are expressing a protein for structural studies, consider removing or truncating treat-category regions to improve crystallization or cryo-EM sample quality. If you are designing domain constructs for biochemical assays, use trust-category boundaries to define domain limits. The pLDDT profile can reveal domain boundaries that are not obvious from sequence analysis alone, particularly when the boundaries fall in low-confidence linker regions.

### A Worked Example Using the Kinase Activation Loop

The protein kinase modeling study provides a concrete example of how the triage framework operates in practice. The researchers needed to produce models of all 437 catalytically competent human protein kinase domains in their active form. Only 155 of these kinases had experimental structures in the Protein Data Bank, so the researchers relied on AlphaFold2 predictions for the remainder.

The critical region for kinase function is the activation loop, which must adopt a specific conformation to bind ATP, magnesium, and substrate. The researchers used pLDDT scores of the activation loop residues as a model selection criterion. They generated multiple models for each kinase and selected the model with the highest pLDDT scores for the activation loop residues. This approach produced models where 80 percent of the highest-scoring predictions had root mean square deviation below 1.0 angstrom and 90 percent had root mean square deviation below 2.0 angstrom compared to experimental substrate-bound structures.

This example illustrates the test category in action. The activation loop is a functionally critical region, but its conformation is difficult to predict because it is flexible and adopts different conformations depending on the activation state. The researchers did not simply trust the first model produced by AlphaFold2. Instead, they treated the activation loop as a test-category region, generated multiple models, and used pLDDT as a selection criterion to identify the most confident prediction. This approach is directly transferable to other proteins with functionally important flexible regions.

### Building a pLDDT Decision Record

A structured decision record helps you document your pLDDT-based choices and provides a basis for revisiting predictions as new information becomes available. For each protein you analyze, create a record that includes the following components.

First, document the sequence and the prediction parameters. Record the exact amino acid sequence used for the prediction, the AlphaFold version, the database versions, and any non-default parameters. This information is essential for reproducibility because different versions of AlphaFold can produce different predictions for the same sequence.

Second, record the pLDDT distribution and the confidence band assignments. Calculate the mean pLDDT, the median pLDDT, and the fraction of residues in each confidence band. Map the confidence bands to the sequence and identify the residue ranges in each category. This provides a permanent record of which regions you considered trustworthy at the time of the analysis.

Third, document the decisions you made based on the pLDDT assignments. For each research task, record which residues you included or excluded and why. If you excluded a low-confidence region from docking calculations, note that decision. If you selected a model based on activation loop pLDDT scores, document the selection criteria and the scores for the selected model.

Fourth, record any validation evidence. If you compared the prediction with an experimental structure, cross-linking data, or mutagenesis results, document the outcome. This evidence helps you calibrate your interpretation of pLDDT scores for future predictions and provides a basis for updating your confidence in the model.

### Troubleshooting Common Decision Points

Several recurring decision points arise when applying the triage framework. The first is the boundary between the trust and test categories. The threshold of 70 is a practical heuristic, not a physical constant. The relationship between pLDDT and accuracy varies by protein family, residue type, and structural context. If you have experimental data for homologous proteins, you can calibrate the threshold for your specific system. For example, if you find that residues with pLDDT above 65 consistently match experimental structures in your protein family, you can adjust your trust threshold accordingly.

The second decision point is the treatment of residues with intermediate pLDDT values in functionally important regions. The kinase activation loop example shows that low or intermediate pLDDT in a critical region does not mean the region is uninterpretable. It means that you need additional evidence or a model selection strategy. Generating multiple models and selecting based on regional pLDDT is one approach. Comparing predictions from different methods is another. Experimental validation is the most definitive approach.

The third decision point is the interpretation of pLDDT in the context of protein dynamics. Research has shown that pLDDT scores correlate with residue flexibility for most folded proteins. Low pLDDT regions are often flexible regions that move significantly in molecular dynamics simulations. This correlation means that a low pLDDT region is not necessarily an error. It may be a correctly identified flexible region. The distinction between error and flexibility is important for interpretation. If you are studying protein dynamics, a low pLDDT region may be biologically meaningful. If you are studying a static structure, the same region may be unreliable.

The fourth decision point is the handling of multimeric complexes. AlphaFold2 performs markedly worse for multimers than for monomers. The pLDDT scores for interface regions in multimeric predictions may be less reliable than the scores for monomer cores. If you are working with a protein complex, you should validate interface predictions experimentally or treat them with extra caution. The triage framework should be applied more conservatively for multimeric systems.

### Integrating the Framework with Existing Analysis Tools

The triage framework can be integrated with existing bioinformatics tools and workflows. The Galaxy Training Network provides accessible workflow training and analysis tutorials that can help you build reproducible pipelines for pLDDT analysis. The nf-core documentation describes community pipeline standards for reproducible workflow configuration, which can help you standardize your prediction and analysis steps. The Carpentries lessons provide foundational computing and data skills that are useful for managing and analyzing structural prediction outputs.

For researchers working with large numbers of proteins, the framework can be automated. You can write scripts that parse AlphaFold output files, calculate pLDDT summary statistics, assign confidence bands, and generate decision records. The Bioconductor project provides official package and workflow documentation for reproducible genomic analysis, and similar principles can be applied to structural prediction analysis. The NCBI Data Resources provide access to sequence databases and analysis services that can support your multiple sequence alignment construction and homolog identification.

The EMBL-EBI Training resources offer bioinformatics learning pathways that can help you develop the skills needed to implement and document your pLDDT analysis workflow. These resources are particularly useful for researchers who are new to structural bioinformatics or who want to formalize their analysis procedures.

### Escalation Criteria Within the Framework

The triage framework includes explicit escalation criteria that indicate when you should move beyond pLDDT-based analysis to more sophisticated methods or experimental approaches. These criteria help you recognize when the confidence scores are insufficient for your research question.

Escalate to experimental structure determination when the mean pLDDT of your model is below 50 or when the functionally critical regions fall in the treat category. If you cannot confidently interpret the regions that matter for your research question, experimental methods such as X-ray crystallography, cryo-electron microscopy, or nuclear magnetic resonance spectroscopy may be necessary.

Escalate to complementary computational methods when the pLDDT scores are ambiguous or when you need information that pLDDT does not provide. Molecular dynamics simulations can characterize the dynamics of low-confidence regions. Homology modeling using experimental structures of related proteins can provide alternative conformations. Docking calculations with flexible receptor treatments can account for conformational uncertainty in binding sites.

Escalate to experimental validation when your conclusions depend on the structure of test-category or treat-category regions. Cross-linking mass spectrometry can provide distance constraints that validate or refute predicted domain arrangements. Hydrogen-deuterium exchange can identify solvent-exposed and flexible regions. Mutagenesis combined with functional assays can test predictions about functionally important residues.

### Documentation Standards for Decision Records

The decision record should follow documentation standards that support reproducibility and communication. Record the date of the analysis and the version of all software and databases used. Describe the sequence and any modifications such as tags or truncations. Report the pLDDT summary statistics and the confidence band assignments. Document the decisions made and the rationale for each decision. Record any validation evidence and the outcome of the validation.

This documentation serves multiple purposes. It allows you to revisit your analysis as new information becomes available. It provides a basis for communicating your confidence in the prediction to collaborators and reviewers. It supports the reproducibility of your research by providing a complete record of the analysis steps and decisions. For laboratory professionals, the documentation also supports quality control and audit requirements.

The decision framework described in this section provides a systematic method for translating pLDDT scores into research actions. By categorizing residues into trust, test, and treat categories, you can make consistent decisions about which regions to use for which purposes. The framework is flexible enough to accommodate protein-specific calibration and rigorous enough to support reproducible research. The kinase activation loop example demonstrates the practical value of using pLDDT as a model selection criterion for functionally important regions. The escalation criteria ensure that you recognize when pLDDT-based analysis is insufficient and when you need to pursue additional methods.

## Frequently Asked Questions

### What does a pLDDT score of 90 mean for a specific residue?

A pLDDT score of 90 indicates very high predicted confidence for that residue. In benchmark studies, residues with pLDDT above 90 are typically modeled with backbone accuracy approaching experimental structures. The residue is likely in a well-structured region of the protein with strong evolutionary constraints. You can use this region for detailed structural analysis such as active site characterization or docking studies.

### How should I interpret pLDDT scores between 50 and 70?

pLDDT scores between 50 and 70 indicate low confidence. These regions may have errors in loop geometry or side chain placement, and the overall topology is generally preserved but the fine details are uncertain. You should avoid using these regions for fine-grained analysis such as docking or binding site characterization. The regions may be flexible loops or surface segments that adopt multiple conformations.

### Can I use pLDDT to identify disordered regions in my protein?

Yes, pLDDT is a useful tool for identifying intrinsically disordered regions. Residues with pLDDT below 50 are often found in disordered segments. Research has shown that AlphaFold2 performs well in predicting intrinsically disordered regions from sequence, and solvent accessibility is a robust proxy for disorder. However, pLDDT indicates that a region is likely disordered but does not provide information about the conformational ensemble of the disordered region.

### Why do some high pLDDT regions still differ from experimental structures?

High pLDDT regions can still differ from experimental structures for several reasons. The relationship between pLDDT and accuracy varies by residue type and structural context. Surface residues, particularly polar and charged residues, tend to be less accurately modeled than buried hydrophobic residues. Proline conformations are particularly challenging. Additionally, the presence of ligands, cofactors, or binding partners can induce conformational changes that are not captured in the apo prediction.

### How does pLDDT relate to protein dynamics?

pLDDT scores correlate with residue flexibility for most folded proteins. Research has shown that pLDDT-derived scores correlate highly with root mean square fluctuations from molecular dynamics simulations for globular proteins, multi-domain proteins, and protein complexes. Low pLDDT regions are often flexible regions. However, this correlation does not hold for intrinsically disordered proteins and randomized proteins, where the pLDDT reflects uncertainty about the structure instead of specific dynamic behavior.

### Should I use pLDDT scores when interpreting missense variants?

pLDDT scores can inform variant interpretation, but they should not be used in isolation. A missense variant in a high pLDDT region is more likely to have a structural effect because the region is confidently modeled. A variant in a low pLDDT region may be in a flexible or disordered segment where structural disruption is less likely. Computational frameworks such as VarMeter2 integrate pLDDT confidence scores with other structural parameters to improve variant effect prediction.

### What is the difference between pLDDT and predicted aligned error?

pLDDT measures local confidence for each residue, while predicted aligned error measures the expected error in the relative position of two residues or domains. pLDDT tells you whether a specific region is confidently modeled, while predicted aligned error tells you whether the relative orientation of different domains is reliable. Both metrics should be examined for a complete assessment of model quality.

### How should I report pLDDT scores in my publications?

Report the pLDDT distribution alongside any structural conclusions. Include the mean pLDDT, the fraction of residues in each confidence band, and the location of low-confidence regions. Document the AlphaFold version and database versions used for the prediction. This information allows readers to assess the reliability of the structural analysis and to reproduce the prediction.

## Related Bioinformatics Guides

- [Volcano Plot Proteomics: How to Create and Interpret Them Effectively](/knowledge/bioinformatics/volcano-plot-proteomics-how-to-create-and-interpret-them-effectively)
- [Metagenomics and Microbiome: Understanding the Link](/knowledge/bioinformatics/metagenomics-and-microbiome-understanding-the-link)
- [Genomic Data vs Genetic Data: Understanding the Differences and Applications](/knowledge/bioinformatics/genomic-data-vs-genetic-data-understanding-the-differences-and-applications)
- [How to Interpret Gene Set Enrichment Analysis Results](/knowledge/bioinformatics/how-to-interpret-gene-set-enrichment-analysis-results)
- [Lipidomic Analysis: A Beginner's Guide to Workflows and Data Interpretation](/knowledge/bioinformatics/lipidomic-analysis-a-beginner-s-guide-to-workflows-and-data-interpretation)

## References and Further Reading

- [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information.
- [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute.
- [Bioconductor](https://bioconductor.org/). Bioconductor Project.
- [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project.
- [nf-core Documentation](https://nf-co.re/docs). nf-core.
- [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries.
- [Assessment of AlphaFold2 for Human Proteins via Residue Solvent Exposure.](https://pubmed.ncbi.nlm.nih.gov/35785970). Journal of chemical information and modeling, 2022.
- [VarMeter: a prediction method for the impact of glycogene variants.](https://pubmed.ncbi.nlm.nih.gov/40629178). Journal of human genetics, 2025.
- [AlphaFold2 models indicate that protein sequence determines both structure and dynamics.](https://pubmed.ncbi.nlm.nih.gov/35739160). Scientific reports, 2022.
- [Modeling intrinsically disordered regions from AlphaFold2 to AlphaFold3.](https://pubmed.ncbi.nlm.nih.gov/41454828). Protein science : a publication of the Protein Society, 2026.
- [AlphaFold2 models of the active form of all 437 catalytically competent human protein kinase domains.](https://pubmed.ncbi.nlm.nih.gov/37547017). bioRxiv : the preprint server for biology, 2023.

> This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.